BioSpace News Archive

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today its oncology-focused subsidiary, Sapphire Biotech, Inc. (“Sapphire”), filed a utility patent application relating to a novel biomarker for the detection of cancer in blood serum and urine. “Sapphire’s diagnostics products have the potential to chang

Biosight Ltd ., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, today announced the appointment of Gary Gordon, M.D., Ph.D., the former Vice President of Oncology Development at AbbVie, to its Board of Directors. “We are thrilled to have Dr. Gordon join the Board at such an exciting time in the advancement of our lead product BST-236,” said Dr. Ruth Ben Yakar, Chief E

PerkinElmer, Inc. (NYSE: PKI) supports government efforts to identify and prevent abusive practices in healthcare. PerkinElmer has received subpoenas from the government regarding investigations into third parties, and has fully cooperated with authorities and will continue to do so.

May 18, 2020 13:44 UTC New crowdsourced protocol builder leverages patient and clinician engagement to design more efficient clinical trials BOSTON--( BUSINESS WIRE )-- Transparency Life Sciences (TLS) today announced the debut of a novel patient-centric protocol builder for clinical trials called Transparency Protocol Crowdsourcing © (TPC). A combination of technology and service, TPC engages patients, physicians, and researchers to contribute to the setup and design of

Everlywell, the digital health company which offers individuals access to at-home collection lab tests for cholesterol, diabetes, STIs, hormones, and more, today announced that the company has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a COVID-19 at-home collection kit.

With more than 4.6 million infections, 300 thousand deaths and counting caused by COVID-19, national governments, healthcare systems regardless of region and continent have been scrambling to respond to it, and the pandemic has highlighted the increasing demand for digital technologies to replace our old way of communication.

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the closing of a transaction resulting in gross cash proceeds to the company of approximately $6.8 million,

In lieu of a daily in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Thursday, May 21, 2020, at 8:30 a.m. ET to review its first quarter 2020 financial results and provide an update on the company. The webcast will be available on the “Investors” section of the Gamida Cell websit

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer (NSCLC). Now, physicians will be able to use the PD-L1 IHC 28-8 pharmDx assay as an aid in identifying patients with metastatic NSCLC